Claims
- 1. The salt of an alkylated and crosslinked polymer comprising the reaction product of:(a) one or more polymers, or salts and copolymers thereof having a repeat unit selected from the group consisting of: and (NR—CH2CH2—NR—CH2CH2—NR—CH2CHOH—CH2)n (3) where n is a positive integer and each R, independently, is H or a C1-C8 alkyl group;(b) at least one aliphatic alkylating agent; and (c) a crosslinking agent, wherein said reaction product has: (i) at least some of the nitrogen atoms in said repeat units unreacted with said alkylating agent; (ii) less than 10 mol % of the nitrogen atoms in said repeat units reacting with said alkylating agent forming quaternary ammonium units; and (iii) a fixed positive charge and one or more counterions and wherein the polymer is alkylated prior to crosslinking.
- 2. The polymer salt of claim 1 wherein at least one of said counterions is Cl−, Br−, CHOSO3−, HSO4−, SO42−, HCO3−, CO32−.
- 3. The polymer salt of claim 1 wherein said polymer is crosslinked by means of a multifunctional crosslinking agent, said agent being present in an amount from about 0.5-25% by weight, based upon the combined weight of monomer and crosslinking agent.
- 4. The polymer salt of claim 1 wherein the crosslinking agent comprises epichlorohydrin.
- 5. The polymer salt of claim 1 wherein said alkylating agent has the formula RX where R is a C1-C20 alkyl, C1-C20 hydroxyalkyl, C1-C20 alkylammonium, or C1-C20 alkylamido group and X is one or more electrophilic leaving groups.
- 6. The polymer salt of claim 5 wherein said alkylating agent comprises a C1-C20 alkyl halide.
- 7. The polymer salt of claim 5 wherein said alkylating agent comprises a C1-C20 alkyl halide ammonium salt.
- 8. The polymer salt of claim 7 wherein said alkyl halide ammonium salt is a C4-C12 haloalkyl trimethylammonium salt.
- 9. The polymer salt of claim 1 wherein said polymer is reacted with at least two of said alkylating agent, one of said alkylating agents has the formula RX where R is a C1-C20 alkyl group and X is one or more electrophilic leaving groups, and the other of said alkylating agents has the formula R′X where R′ is a C1-C20 alkyl ammonium group and X is one or more electrophilic leaving groups.
- 10. The polymer salt of claim 9 wherein one of said alkylating agents having the formula RX is an alkyl halide and the other of said alkylating agents having the formula R′X is an alkyl halide ammonium salt.
- 11. The polymer salt of claim 10 wherein said alkyl halide is a C4-C20 alkyl halide band said alkyl halide ammonium salt is a C4-C8 alkyl halide ammonium salt.
- 12. The polymer salt of claim 11 wherein said alkyl halide is a C10 alkyl halide and said alkyl halide ammonium salt is a C6 alkyl halide trimethyl ammonium salt.
- 13. A method for removing bile salts from a patient comprising administering to said patient a therapeutically effective amount of the salt of an alkylated and crosslinked polymer comprising the reaction product of:(a) one or more polymers, or salts and copolymers thereof having a repeat unit selected from the group consisting of: and (NR—CH2CH2—NR—CH2CH2—NR—CH2CHOH—CH2)n (3) where n is a positive integer and each R, independently, is H or a C1-C8 alkyl group;(b) at least one aliphatic alkylating agent; and (c) a crosslinking agent, wherein in the reaction product has: (i) at least some of the nitrogen atoms in said repeat units unreacted with said alkylating agent; (ii) less than 10 mol % of the nitrogen atoms in said repeat units reacting with said alkylating agent forming quaternary ammonium units; and (iii) a fixed positive charge and one or more counterions and wherein the polymer is alkylated prior to crosslinking.
- 14. The method of claim 1 wherein at least one of said counterions is Cl−, Br−, CHOSO3−, HSO4−, SO42−, HCO3−, CO32−.
- 15. The method of claim 13 wherein said polymer salt is crosslinked by means of a multifunctional crosslinking agent, said agent being present in an amount from about 0.5-25% by weight, based upon the combined weight of monomer and crosslinking agent.
- 16. The method of claim 15 wherein the crosslinking agent comprises epichlorohydrin.
- 17. The method of claim 13 wherein said alkylating agent has the formula RX where R is a C1-C20 alkyl, C1-C20 hydroxyalkyl, C1-C20 alkylammonium, or C1-C20 alkylamido group and X is one or more electrophilic leaving groups.
- 18. The method of claim 17 wherein said alkylating agent comprises a C1-C20 alkyl halide.
- 19. The method of claim 17 wherein said alkylating agent comprises a C1-C20 alkyl halide ammonium salt.
- 20. The method of claim 19 wherein said alkyl halide ammonium salt is a C4-C12 haloalkyl trimethylarnmonium salt.
- 21. The method of claim 13 wherein said polymer salt is reacted with at least two of said alkylating agent, one of said alkylating agents has the formula RX where R is a C1-C20 alkyl group and X is one or more electrophilic leaving groups, and the other of said alkylating agents has the formula R′X where R′ is a C1-C20 alkyl ammonium group and X is one or more electrophilic leaving groups.
- 22. The method of claim 21 wherein one of said alkylating agents having the formula RX is an alkyl halide and the other of said alkylating agents having the formula R′X is an alkyl halide ammonium salt.
- 23. The method of claim 22 wherein said alkyl halide is a C4-C20 alkyl halide and said alkyl halide ammionium salt is a C4-C18 alkyl halide ammonium salt.
- 24. The method of claim 23 wherein said alkyl halide is a C10 alkyl halide and said alkyl halide ammonium salt is a C6 alkyl halide trimethyl ammonium salt.
RELATED APPLICATIONS
This application is a continuation of U.S. Ser. No. 09/388,876 filed Sep. 2, 1999 now U.S. Pat. No. 6,066,678, which is a continuation of U.S. Ser. No. 09/288,357 filed Apr. 8, 1999 now U.S. Pat. No. 5,981,693, which is a continuation of U.S. Ser. No. 09/129,286 filed Aug. 5, 1998, now U.S. Pat. No. 5,917,007, which is a continuation of U.S. Ser. No. 08/910,692 filed Aug. 13, 1997, now abandoned, which is a divisional of U.S. Ser. No. 08/460,980 filed on Jun. 5, 1995, now U.S. Pat. No. 5,679,717, which is a continuation-in-part of U.S. Ser. No. 08/258,431 filed Jun. 10, 1994, now abandoned, the entire teachings of all of which are incorporated herein by reference.
US Referenced Citations (29)
Foreign Referenced Citations (10)
Number |
Date |
Country |
0 162 388 |
Nov 1985 |
EP |
0432995A1 |
Jun 1991 |
EP |
0580079A1 |
Jan 1994 |
EP |
0580078A1 |
Jan 1994 |
EP |
929391 |
Jun 1963 |
GB |
1567294 |
May 1980 |
GB |
WO9118027 |
Nov 1991 |
WO |
WO9210522 |
Jun 1992 |
WO |
WO9404596 |
Mar 1994 |
WO |
WO9427620 |
Dec 1994 |
WO |
Non-Patent Literature Citations (2)
Entry |
Heming, A.E. and Flanagan, Thomas L., “Considerations in the Selection of Cation Exchange Resins for Therapeutic Use,” Annals of the New York Academy of Sciences, 57:239-251 (1954). |
McCarthy, Peter A., “New Approaches to Atherosclerosis: An Overview,” Medicinal Research Reviews, 13(2):139-159 (1993). |
Continuations (4)
|
Number |
Date |
Country |
Parent |
09/388876 |
Sep 1999 |
US |
Child |
09/532984 |
|
US |
Parent |
09/288357 |
Apr 1999 |
US |
Child |
09/388876 |
|
US |
Parent |
09/129286 |
Aug 1998 |
US |
Child |
09/288357 |
|
US |
Parent |
08/910692 |
Aug 1997 |
US |
Child |
09/129286 |
|
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
08/258431 |
Jun 1994 |
US |
Child |
08/460980 |
|
US |